Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    October 05-06, 2022

    27th Asia-Pacific Dermatology Conference

    Amsterdam, Netherlands
    October 21-21, 2022

    24th World Dermatology and Aesthetic Congress

    Osaka, Japan
    November 14-15, 2022

    Asian Aesthetic and Dermatology congress

    Amsterdam, Netherlands
    November 17-18, 2022

    5th World Cosmetic and Dermatology Congress

    London, UK
    December 05-06, 2022

    Global Meet on Skin Care and Plastic Aesthetics

    Amsterdam, Netherlands
    December 15-16, 2022

    5th International Dermatology Conference: Skin and Body

    Prague, Czech Republic
    March 01-02, 2023

    7th International Congress on Dermatology

    Berlin, Germany
    May 22-23, 2023

    24th World Dermatology Congress

    Barcelona, Spain
    July 27-28, 2023

    23rd European Dermatology Congress

    Paris, France
    November 20-21, 2023

    3rd Global Summit on Skincare and Plastic Aesthetic

    Bangkok, Thailand

    Pigmentary disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in